ArticleScientific reports2025

CD38-specific nanobody-based bispecific antibody recruiters (BARs) redirect complement-dependent cytotoxicity toward multiple myeloma cells.

Luca Julius Pape et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.